CID 16077846

1-[2-[3-[4-[[2-[1-(4-tert-butyl-2-chloro-phenyl)tetrazol-5-yl]sulfanylacetyl]amino]-3-chloro-phenyl]-1,1-dimethyl-prop-2-ynoxy]acetyl]piperidine-4-carboxylic acid

Structural Information

Molecular Formula
C32H36Cl2N6O5S
SMILES
CC(C)(C)C1=CC(=C(C=C1)N2C(=NN=N2)SCC(=O)NC3=C(C=C(C=C3)C#CC(C)(C)OCC(=O)N4CCC(CC4)C(=O)O)Cl)Cl
InChI
InChI=1S/C32H36Cl2N6O5S/c1-31(2,3)22-7-9-26(24(34)17-22)40-30(36-37-38-40)46-19-27(41)35-25-8-6-20(16-23(25)33)10-13-32(4,5)45-18-28(42)39-14-11-21(12-15-39)29(43)44/h6-9,16-17,21H,11-12,14-15,18-19H2,1-5H3,(H,35,41)(H,43,44)
InChIKey
MQLSFKCLROEACG-UHFFFAOYSA-N
Compound name
1-[2-[4-[4-[[2-[1-(4-tert-butyl-2-chlorophenyl)tetrazol-5-yl]sulfanylacetyl]amino]-3-chlorophenyl]-2-methylbut-3-yn-2-yl]oxyacetyl]piperidine-4-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

686.1845 Da
Monoisotopic Mass

6.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 687.19178 254.6
[M+Na]+ 709.17372 258.4
[M-H]- 685.17722 255.3
[M+NH4]+ 704.21832 249.1
[M+K]+ 725.14766 251.6
[M+H-H2O]+ 669.18176 237.9
[M+HCOO]- 731.18270 243.0
[M+CH3COO]- 745.19835 265.7
[M+Na-2H]- 707.15917 246.8
[M]+ 686.18395 253.1
[M]- 686.18505 253.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.